, Tracking Stock Market Picks
Enter Symbol:
galena biopharma (GALE) [hlAlert]

down 47.16 %

galena biopharma (GALE) rated Buy with price target $6 by ROTH Capital

Posted on: Tuesday,  Nov 10, 2015  8:25 AM ET by Roth Capital

Roth Capital rated Buy galena biopharma (NASDAQ: GALE) on 11/10/2015. Previously Roth Capital rated Buy galena biopharma (NASDAQ: GALE) on 03/18/2014.,
when the stock price was $2.82. Since then, galena biopharma has lost 47.16% as of 01/21/2016's recent price of $1.49.
If you would have followed the previous Roth Capital's recommendation on GALE, you would have lost 47.16% of your investment in 674 days.

RXi Pharmaceuticals Corporation (RXi) is a discovery-stage biopharmaceutical company pursuing therapeutics based on ribonucleic acid interference (RNAi) for the treatment of human diseases. The Company is focused on internal research and development programs on certain inflammatory and metabolic diseases, and to pursue other therapeutic areas with potential partners. RXi commenced operations after CytRx Corporation contributed to the Company its portfolio of RNAi therapeutic assets, which consisted primarily of RNAi licenses and related intellectual property, and a nominal amount of equipment. As of December 31, 2008, the Company had not generated any revenues.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/10/2015 8:25 AM Buy
1.46 6.00
as of 8/27/2015
1 Week down  -1.32 %
1 Month down  -23.19 %
3 Months up  9.55 %
1 YTD down  -47.16 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/18/2014 8:25 AM Buy
2.82 7.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy